Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalmefene pretreatment to reduce sufentanil-induced cough during general anesthesia induction
ChiCTR2200057284Phase 4Recruiting
- Sponsor
- Peking University Shougang Hospital
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of nalmefene (3 arms), sponsored by Peking University Shougang Hospital. Primary endpoint: classification of cough. Started Apr 2022; status: recruiting.
02
Drugs
nalmefene
Beyond the preview
Go deeper on ChiCTR2200057284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057284.